About the Company
We do not have any company description for Co-Diagnostics, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
80
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Co-Diagnostics, Inc.
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox ...
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the ...
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates
Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.25 per share a year ago. These ...
Co-Diagnostics, Inc. Commemorates Third Anniversary of the ... - Nasdaq
Co-Diagnostics also announced today that it would be hosting a booth at the upcoming BioHive and BioUtah Life Sciences Day on the Hill, on January 27, 2023 from 11:00 AM to 2:00 PM at the Utah ...
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite ...
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 Jan. 07, 2025 9:30 AM ET Co-Diagnostics, Inc. (CODX) ...
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of ...
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro
SALT LAKE CITY, Dec. 27, 2023 /PRNewswire/ -- Co-Diagnostics (CODX), Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the ...
Co-Diagnostics, Inc. Announces Completion of the Acquisition of all ...
--Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the acquisition of ...
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development ...
Co-Diagnostics, Inc. to Present its Rapid Response to New Coronavirus ...
The Company’s presentation is scheduled to take place on Saturday, February 15 th at 12:45 PM, and will be conducted jointly by its CSO and Head of International Sales. About Co-Diagnostics, Inc.: ...
Co-Diagnostics, Inc. Announces Successful Initial Verification of Novel ...
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology.
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit
On June 15, 2020, Plaintiff Gelt Trading, Ltd. filed a securities class action against Co-Diagnostics, Inc. and certain of the Company's current and former directors and officers alleging ...
Similar Companies
Loading the latest forecasts...